Stock listing
Lotus Pharmaceutical Co., Ltd.
Selected listing: 1795 · TWSE · TWD · TW
Lotus Pharmaceutical Co., Ltd. (TWSE:1795), Health Technology. Latest release May 22, 2026: Lotus Pharmaceutical Announces Acquisition of a Specialty…
- Ticker
- TWSE:1795
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TWSE
- Currency
- TWD
About Lotus Pharmaceutical Co., Ltd.
Lotus Pharmaceutical Co., Ltd. is a publicly traded company on the Taiwan stock market under the ticker 1795. The company is committed to innovation and quality in its product offerings.
Latest news from Lotus Pharmaceutical Co., Ltd.
Lotus Pharmaceutical Announces Acquisition of a Specialty Pharmaceutical Product in South Korea, Expanding Portfolio in Urology and Infectious Disease Prevention
May 22, 2026
Lotus Reports October 2025 Revenue of NT$2,753 Million
November 11, 2025
Lotus Enters License and Supply Agreement with Adalvo for Semaglutide injection
October 6, 2025
Alvogen Announces Sale to Lotus, Creating a Leading International Specialized Generics Platform
September 23, 2025
Lotus Pharmaceutical reports August 2025 Revenue of NT$1,160 Million
September 11, 2025
Research Lotus Pharmaceutical Co., Ltd.
Lotus Pharmaceutical Co., Ltd. company profile
View the public company page for Lotus Pharmaceutical Co., Ltd. on 6ix.
Lotus Pharmaceutical Co., Ltd. news
Read company news and market updates connected to Lotus Pharmaceutical Co., Ltd..
Lotus Pharmaceutical Co., Ltd. investor events
Find investor webinars, events, and replay context for Lotus Pharmaceutical Co., Ltd..